Study of chemicals in head and neck cancer samples
Part of Cancer, Ear, nose & throat clinical trials.
This study looks at the chemical signatures (metabolomics) in blood and tumor tissue from people with head and neck cancer. It aims to find markers that may help predict treatment response or tailor future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a type of head and neck cancer called squamous cell carcinoma, located in the mouth, throat, voice box, or lower throat area.
- Your cancer must not have spread to other parts of the body (no distant metastases).
- You have not had any other cancer (except a common skin cancer) in the last 5 years.
- You are planning to receive treatment that aims to cure your cancer at the study hospital (Centre Antoine Lacassagne).
- You agree to allow researchers to use your stored tissue and blood samples for study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether certain blood tests can help predict how head and neck cancer will respond to treatment. If you are planning surgery for squamous cell cancer of the throat, voice box, or mouth, this trial may offer more information about your outlook.
This study looks at “immune signals” in blood, saliva, and stool to learn more about head and neck cancers (especially squamous cell carcinoma). It may help researchers find patterns that improve understanding of disease or how treatment should be guided.
This study collects tissue from people with newly diagnosed head and neck squamous cell cancer and grows “mini tumor models” in the lab. The goal is to see how these models respond to new therapies, which may help guide more effective treatment choices in the future.
This study looks at the natural bacteria in and around head and neck tumors compared to healthy tissue. The goal is to understand if these bacteria affect cancer growth and treatment. By participating, you help researchers learn more about this type of cancer.
This study collects blood and tumor tissue samples to analyze biological markers in patients with advanced head and neck squamous cell carcinoma before starting immunotherapy. The goal is to better understand how these markers relate to treatment response.
This study looks at tumor samples from people with head and neck cancer to understand why some treatments stop working. By studying the tumor tissue, researchers hope to find better ways to treat this cancer in the future.
Hear when a new Upper AerodigestiveTract Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.